Desmosomes in acquired disease

Cell and Tissue Research

Volumn 360, Issue 3, 2015, Pages 439-456

  Stahley, Sara N ^a   Kowalczyk, Andrew P ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bullous disease; Cadherin; Cancer; Cell adhesion; Desmoglein; Pemphigus

Indexed keywords

DESMOCOLLIN; DESMOCOLLIN 1; DESMOCOLLIN 2; DESMOCOLLIN 3; DESMOGLEIN; DESMOPLAKIN; DESMOSOMAL CADHERIN; DESOMPLAKIN; IMMUNOGLOBULIN A ANTIBODY; PLAKOPHILIN; PLAKOPHILIN 1; PLAKOPHILIN 2; UNCLASSIFIED DRUG;

ACANTHOLYSIS; ACQUIRED DESMOSOMAL DISEASE; AUTOIMMUNE DISEASE; BACILLUS ANTHRACIS; BULLOUS SKIN DISEASE; CANDIDIASIS; CELL ADHESION; CELL FUNCTION; COXSACKIE VIRUS INFECTION; COXSACKIEVIRUS B3; DESMOSOME; DOWN REGULATION; ENDOCYTOSIS; GIARDIA INTESTINALIS; HUMAN; IGA PEMPHIGUS; INFECTION; INTRACELLULAR SIGNALING; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR DYNAMICS; NONHUMAN; PARANEOPLASTIC PEMPHIGUS; PATHOGENESIS; PEMPHIGUS; PEMPHIGUS FOLIACEUS; PEMPHIGUS VULGARIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; REVIEW; STEREOSPECIFICITY; ANIMAL; BIOLOGICAL MODEL; METABOLISM; PATHOLOGY; SKIN DISEASE;

ANIMALS; DESMOSOMES; HUMANS; MODELS, BIOLOGICAL; SKIN DISEASES;

EID: 84930276235     PISSN: 0302766X     EISSN: 14320878     Source Type: Journal    
DOI: 10.1007/s00441-015-2155-2     Document Type: Review

References (201)

1. Al-Amoudi A, Frangakis AS (2008) Structural studies on desmosomes. Biochem Soc Trans 36:181–187
2. Al-Jassar C, Bikker H, Overduin M, Chidgey M (2013) Mechanistic basis of desmosome-targeted diseases. J Mol Biol 425:4006–4022
3. Allen CM, Camisa C (2000) Paraneoplastic pemphigus: a review of the literature. Oral Dis 6:208–214
4. Almeida Junior HL de, Wolter M, Castro LA, Rocha NE (2001) Papular acantholytic dyskeratosis. Hautarzt 52:1101–1103
5. Amagai M (1999) Autoimmunity against desmosomal cadherins in pemphigus. J Dermatol Sci 20:92–102
6. Amagai M (2009) The molecular logic of pemphigus and impetigo: the desmoglein story. Vet Dermatol 20:308–312
7. Amagai M (2010) Autoimmune and infectious skin diseases that target desmogleins. Proc Jpn Acad Ser B Phys Biol Sci 86:524–537
8. Amagai M, Stanley JR (2012) Desmoglein as a target in skin disease and beyond. J Invest Dermatol 132:776–784
9. Amagai M, Klaus-Kovtun V, Stanley JR (1991) Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion. Cell 67:869–877
10. Amagai M, Karpati S, Prussick R, Klaus-Kovtun V, Stanley JR (1992) Autoantibodies against the amino-terminal cadherin-like binding domain of pemphigus vulgaris antigen are pathogenic. J Clin Invest 90:919–926
11. Amagai M, Hashimoto T, Shimizu N, Nishikawa T (1994) Absorption of pathogenic autoantibodies by the extracellular domain of pemphigus vulgaris antigen (Dsg3) produced by baculovirus. J Clin Invest 94:59–67
12. Amagai M, Hashimoto T, Green KJ, Shimizu N, Nishikawa T (1995) Antigen-specific immunoadsorption of pathogenic autoantibodies in pemphigus foliaceus. J Invest Dermatol 104:895–901
13. Amagai M, Nishikawa T, Nousari HC, Anhalt GJ, Hashimoto T (1998) Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice. J Clin Invest 102:775–782
14. Amagai M, Matsuyoshi N, Wang ZH, Andl C, Stanley JR (2000) Toxin in bullous impetigo and staphylococcal scalded-skin syndrome targets desmoglein 1. Nat Med 6:1275–1277
15. Amerian ML, Ahmed AR (1985) Pemphigus erythematosus. Senear-Usher syndrome. Int J Dermatol 24:16–25
16. Anand P, Kunnumakkara AB, Sundaram C, Harikumar KB, Tharakan ST, Lai OS, Sung B, Aggarwal BB (2008) Cancer is a preventable disease that requires major lifestyle changes. Pharm Res 25:2097–2116
17. Anhalt GJ, Labib RS, Voorhees JJ, Beals TF, Diaz LA (1982) Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. N Engl J Med 306:1189–1196
18. Anhalt GJ, Kim SC, Stanley JR, Korman NJ, Jabs DA, Kory M, Izumi H, Ratrie H 3rd, Mutasim D, Ariss-Abdo L, Labib RS (1990) Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med 323:1729–1735
19. Aoki V, Sousa JX Jr, Diaz LA, Cooperative Group on Fogo Selvagem R (2011) Pathogenesis of endemic pemphigus foliaceus. Dermatol Clin 29:413–418
20. Aoyama Y, Kitajima Y (1999) Pemphigus vulgaris-IgG causes a rapid depletion of desmoglein 3 (Dsg3) from the Triton X-100 soluble pools, leading to the formation of Dsg3-depleted desmosomes in a human squamous carcinoma cell line, DJM-1 cells. J Invest Dermatol 112:67–71
21. Ariyawardana A, Tilakaratne WM, Dissanayake M, Vitanaarachchi N, Basnayake LK, Sitheeque MA, Ranasinghe AW (2005) Oral pemphigus vulgaris in children and adolescents: a review of the literature and a case report. Int J Paediatr Dent 15:287–293
22. Beaudry VG, Jiang D, Dusek RL, Park EJ, Knezevich S, Ridd K, Vogel H, Bastian BC, Attardi LD (2010) Loss of the p53/p63 regulated desmosomal protein Perp promotes tumorigenesis. PLoS Genet 6:e1001168
23. Bektas M, Jolly PS, Berkowitz P, Amagai M, Rubenstein DS (2013) A pathophysiologic role for epidermal growth factor receptor in pemphigus acantholysis. J Biol Chem 288:9447–9456
24. Berika M, Garrod D (2014) Desmosomal adhesion in vivo. Cell Commun Adhes 21:65–75
25. Berkowitz P, Hu P, Liu Z, Diaz LA, Enghild JJ, Chua MP, Rubenstein DS (2005) Desmosome signaling. Inhibition of p38MAPK prevents pemphigus vulgaris IgG-induced cytoskeleton reorganization. J Biol Chem 280:23778–23784
26. Berkowitz P, Hu P, Warren S, Liu Z, Diaz LA, Rubenstein DS (2006) p38MAPK inhibition prevents disease in pemphigus vulgaris mice. Proc Natl Acad Sci U S A 103:12855–12860
27. Berkowitz P, Diaz LA, Hall RP, Rubenstein DS (2008) Induction of p38MAPK and HSP27 phosphorylation in pemphigus patient skin. J Invest Dermatol 128:738–740
28. Bernard P (2008) Management of common bacterial infections of the skin. Curr Opin Infect Dis 21:122–128
29. Bhol K, Natarajan K, Nagarwalla N, Mohimen A, Aoki V, Ahmed AR (1995) Correlation of peptide specificity and IgG subclass with pathogenic and nonpathogenic autoantibodies in pemphigus vulgaris: a model for autoimmunity. Proc Natl Acad Sci U S A 92:5239–5243
30. Biedermann K, Vogelsang H, Becker I, Plaschke S, Siewert JR, Hofler H, Keller G (2005) Desmoglein 2 is expressed abnormally rather than mutated in familial and sporadic gastric cancer. J Pathol 207:199–206
31. Birchmeier W, Hulsken J, Behrens J (1995) Adherens junction proteins in tumour progression. Cancer Surv 24:129–140
32. Birchmeier C, Birchmeier W, Brand-Saberi B (1996) Epithelial-mesenchymal transitions in cancer progression. Acta Anat 156:217–226
33. Bizzozero G (1864) Delle cellule cigliate del reticolo malpighiano dell’epidermide. Ann Universali Med 190:110–118
34. Bolling MC, Mekkes JR, Goldschmidt WF, van Noesel CJ, Jonkman MF, Pas HH (2007) Acquired palmoplantar keratoderma and immunobullous disease associated with antibodies to desmocollin 3. Br J Dermatol 157:168–173
35. Brennan D, Mahoney MG (2009) Increased expression of Dsg2 in malignant skin carcinomas: a tissue-microarray based study. Cell Adhes Migr 3:148–154
36. Brennan D, Peltonen S, Dowling A, Medhat W, Green KJ, Wahl JK 3rd, Del Galdo F, Mahoney MG (2012) A role for caveolin-1 in desmoglein binding and desmosome dynamics. Oncogene 31:1636–1648
37. Breuninger S, Reidenbach S, Sauer CG, Strobel P, Pfitzenmaier J, Trojan L, Hofmann I (2010) Desmosomal plakophilins in the prostate and prostatic adenocarcinomas: implications for diagnosis and tumor progression. Am J Pathol 176:2509–2519
38. Calkins CC, Setzer SV (2007) Spotting desmosomes: the first 100 years. J Invest Dermatol 127:E2–E3
39. Calkins CC, Setzer SV, Jennings JM, Summers S, Tsunoda K, Amagai M, Kowalczyk AP (2006) Desmoglein endocytosis and desmosome disassembly are coordinated responses to pemphigus autoantibodies. J Biol Chem 281:7623–7634
40. Chan PT, Ohyama B, Nishifuji K, Yoshida K, Ishii K, Hashimoto T, Amagai M (2010) Immune response towards the amino-terminus of desmoglein 1 prevails across different activity stages in nonendemic pemphigus foliaceus. Br J Dermatol 162:1242–1250
41. Chen YJ, Chang JT, Lee L, Wang HM, Liao CT, Chiu CC, Chen PJ, Cheng AJ (2007) DSG3 is overexpressed in head neck cancer and is a potential molecular target for inhibition of oncogenesis. Oncogene 26:467–476
42. Chen YJ, Lee LY, Chao YK, Chang JT, Lu YC, Li HF, Chiu CC, Li YC, Li YL, Chiou JF, Cheng AJ (2013) DSG3 facilitates cancer cell growth and invasion through the DSG3-plakoglobin-TCF/LEF-Myc/cyclin D1/MMP signaling pathway. PLoS One 8:e64088
43. Chernyavsky AI, Arredondo J, Kitajima Y, Sato-Nagai M, Grando SA (2007) Desmoglein versus non-desmoglein signaling in pemphigus acantholysis: characterization of novel signaling pathways downstream of pemphigus vulgaris antigens. J Biol Chem 282:13804–13812
44. Chun MG, Hanahan D (2010) Genetic deletion of the desmosomal component desmoplakin promotes tumor microinvasion in a mouse model of pancreatic neuroendocrine carcinogenesis. PLoS Genet 6:e1001120
45. Cirillo N (2014) 150th anniversary series: desmosomes in physiology and disease. Cell Commun Adhes 21:85–88
46. Cirillo N, Gombos F, Lanza A (2007) Changes in desmoglein 1 expression and subcellular localization in cultured keratinocytes subjected to anti-desmoglein 1 pemphigus autoimmunity. J Cell Physiol 210:411–416
47. Cirillo N, Lanza A, Prime SS (2010) Induction of hyper-adhesion attenuates autoimmune-induced keratinocyte cell-cell detachment and processing of adhesion molecules via mechanisms that involve PKC. Exp Cell Res 316:580–592
48. Cui T, Chen Y, Yang L, Knosel T, Huber O, Pacyna-Gengelbach M, Petersen I (2012a) The p53 target gene desmocollin 3 acts as a novel tumor suppressor through inhibiting EGFR/ERK pathway in human lung cancer. Carcinogenesis 33:2326–2333
49. Cui T, Chen Y, Yang L, Mireskandari M, Knosel T, Zhang Q, Kohler LH, Kunze A, Presselt N, Petersen I (2012b) Diagnostic and prognostic impact of desmocollins in human lung cancer. J Clin Pathol 65:1100–1106
50. Defamie N, Chepied A, Mesnil M (2014) Connexins, gap junctions and tissue invasion. FEBS Lett 588:1331–1338
51. Dehner C, Rotzer V, Waschke J, Spindler V (2014) A desmoplakin point mutation with enhanced keratin association ameliorates pemphigus vulgaris autoantibody-mediated loss of cell cohesion. Am J Pathol 184:2528–2536
52. Delva E, Jennings JM, Calkins CC, Kottke MD, Faundez V, Kowalczyk AP (2008) Pemphigus vulgaris IgG-induced desmoglein-3 endocytosis and desmosomal disassembly are mediated by a clathrin- and dynamin-independent mechanism. J Biol Chem 283:18303–18313
53. Demirag GG, Sullu Y, Gurgenyatagi D, Okumus NO, Yucel I (2011) Expression of plakophilins (PKP1, PKP2, and PKP3) in gastric cancers. Diagn Pathol 6:1
54. Demirag GG, Sullu Y, Yucel I (2012) Expression of plakophilins (PKP1, PKP2, and PKP3) in breast cancers. Med Oncol 29:1518–1522
55. Desai BV, Harmon RM, Green KJ (2009) Desmosomes at a glance. J Cell Sci 122:4401–4407
56. Di Zenzo G, Di Lullo G, Corti D, Calabresi V, Sinistro A, Vanzetta F, Didona B, Cianchini G, Hertl M, Eming R, Amagai M, Ohyama B, Hashimoto T, Sloostra J, Sallusto F, Zambruno G, Lanzavecchia A (2012) Pemphigus autoantibodies generated through somatic mutations target the desmoglein-3 cis-interface. J Clin Invest 122:3781–3790
57. Dmochowski M, Hashimoto T, Garrod DR, Nishikawa T (1993) Desmocollins I and II are recognized by certain sera from patients with various types of pemphigus, particularly Brazilian pemphigus foliaceus. J Invest Dermatol 100:380–384
58. Dusek RL, Attardi LD (2011) Desmosomes: new perpetrators in tumour suppression. Nat Rev Cancer 11:317–323
59. Dusek RL, Bascom JL, Vogel H, Baron S, Borowsky AD, Bissell MJ, Attardi LD (2012) Deficiency of the p53/p63 target Perp alters mammary gland homeostasis and promotes cancer. Breast Cancer Res 14:R65
60. Foedinger D, Anhalt GJ, Boecskoer B, Elbe A, Wolff K, Rappersberger K (1995) Autoantibodies to desmoplakin I and II in patients with erythema multiforme. J Exp Med 181:169–179
61. Foedinger D, Sterniczky B, Elbe A, Anhalt G, Wolff K, Rappersberger K (1996) Autoantibodies against desmoplakin I and II define a subset of patients with erythema multiforme major. J Invest Dermatol 106:1012–1016
62. Foedinger D, Elbe-Burger A, Sterniczky B, Lackner M, Horvat R, Wolff K, Rappersberger K (1998) Erythema multiforme associated human autoantibodies against desmoplakin I and II: biochemical characterization and passive transfer studies into newborn mice. J Invest Dermatol 111:503–510
63. Franzen CA, Todorovic V, Desai BV, Mirzoeva S, Yang XJ, Green KJ, Pelling JC (2012) The desmosomal armadillo protein plakoglobin regulates prostate cancer cell adhesion and motility through vitronectin-dependent Src signaling. PLoS One 7:e42132
64. Furukawa C, Daigo Y, Ishikawa N, Kato T, Ito T, Tsuchiya E, Sone S, Nakamura Y (2005) Plakophilin 3 oncogene as prognostic marker and therapeutic target for lung cancer. Cancer Res 65:7102–7110
65. Futei Y, Amagai M, Hashimoto T, Nishikawa T (2003) Conformational epitope mapping and IgG subclass distribution of desmoglein 3 in paraneoplastic pemphigus. J Am Acad Dermatol 49:1023–1028
66. Gallo E, Garcia-Martin P, Fraga J, Teye K, Koga H, Hashimoto T, Garcia-Diez A (2014) Paraneoplastic pemphigus with eosinophilic spongiosis and autoantibodies against desmocollins 2 and 3. Clin Exp Dermatol 39:323–326
67. Gammon WR, Lewis DM, Carlo JR, Sams WM Jr, Wheeler CE Jr (1980) Pemphigoid antibody mediated attachment of peripheral blood leukocytes at the dermal-epidermal junction of human skin. J Invest Dermatol 75:334–339
68. Getsios S, Huen AC, Green KJ (2004) Working out the strength and flexibility of desmosomes. Nat Rev Mol Cell Biol 5:271–281
69. Getsios S, Waschke J, Borradori L, Hertl M, Muller EJ (2010) From cell signaling to novel therapeutic concepts: international pemphigus meeting on advances in pemphigus research and therapy. J Invest Dermatol 130:1764–1768
70. Gliem M, Heupel WM, Spindler V, Harms GS, Waschke J (2010) Actin reorganization contributes to loss of cell adhesion in pemphigus vulgaris. Am J Physiol Cell Physiol 299:C606–C613
71. Green KJ, Getsios S, Troyanovsky S, Godsel LM (2010) Intercellular junction assembly, dynamics, and homeostasis. Cold Spring Harbor Perspect Biol 2:a000125
72. Gumbiner B, Stevenson B, Grimaldi A (1988) The role of the cell adhesion molecule uvomorulin in the formation and maintenance of the epithelial junctional complex. J Cell Biol 107:1575–1587
73. Hamidov Z, Altendorf-Hofmann A, Chen Y, Settmacher U, Petersen I, Knosel T (2011) Reduced expression of desmocollin 2 is an independent prognostic biomarker for shorter patients survival in pancreatic ductal adenocarcinoma. J Clin Pathol 64:990–994
74. Harada H, Iwatsuki K, Ohtsuka M, Han GW, Kaneko F (1996) Abnormal desmoglein expression by squamous cell carcinoma cells. Acta Derm Venereol 76:417–420
75. Hartman-Adams H, Banvard C, Juckett G (2014) Impetigo: diagnosis and treatment. Am Fam Physician 90:229–235
76. Hashimoto T, Amagai M, Watanabe K, Chorzelski TP, Bhogal BS, Black MM, Stevens HP, Boorsma DM, Korman NJ, Gamou S, Shimizu N, Nishikawa T (1995a) Characterization of paraneoplastic pemphigus autoantigens by immunoblot analysis. J Invest Dermatol 104:829–834
77. Hashimoto T, Amagai M, Watanabe K, Dmochowski M, Chidgey MA, Yue KK, Garrod DR, Nishikawa T (1995b) A case of pemphigus vulgaris showing reactivity with pemphigus antigens (Dsg1 and Dsg3) and desmocollins. J Invest Dermatol 104:541–544
78. Hata T, Nishimoto S, Nagao K, Takahashi H, Yoshida K, Ohyama M, Yamada T, Asano K, Amagai M (2013) Ectopic expression of epidermal antigens renders the lung a target organ in paraneoplastic pemphigus. J Immunol 191:83–90
79. He W, Cowin P, Stokes DL (2003) Untangling desmosomal knots with electron tomography. Science 302:109–113
80. Heupel WM, Zillikens D, Drenckhahn D, Waschke J (2008) Pemphigus vulgaris IgG directly inhibit desmoglein 3-mediated transinteraction. J Immunol 181:1825–1834
81. Hobbs RP, Green KJ (2012) Desmoplakin regulates desmosome hyperadhesion. J Invest Dermatol 132:482–485
82. Holthofer B, Windoffer R, Troyanovsky S, Leube RE (2007) Structure and function of desmosomes. Int Rev Cytol 264:65–163
83. Ihrie RA, Attardi LD (2005) A new Perp in the lineup: linking p63 and desmosomal adhesion. Cell Cycle 4:873–876
84. Iwatsuki K, Takigawa M, Imaizumi S, Yamada M (1989) In vivo binding site of pemphigus vulgaris antibodies and their fate during acantholysis. J Am Acad Dermatol 20:578–582
85. Iwatsuki K, Han GW, Fukuti R, Ohtsuka M, Kikuchi S, Akiba H, Kaneko F (1999) Internalization of constitutive desmogleins with the subsequent induction of desmoglein 2 in pemphigus lesions. Br J Dermatol 140:35–43
86. Jennings JM, Tucker DK, Kottke MD, Saito M, Delva E, Hanakawa Y, Amagai M, Kowalczyk AP (2011) Desmosome disassembly in response to pemphigus vulgaris IgG occurs in distinct phases and can be reversed by expression of exogenous Dsg3. J Invest Dermatol 131:706–718
87. Jolly PS, Berkowitz P, Bektas M, Lee HE, Chua M, Diaz LA, Rubenstein DS (2010) p38MAPK signaling and desmoglein-3 internalization are linked events in pemphigus acantholysis. J Biol Chem 285:8936–8941
88. Joly P, Litrowski N (2011) Pemphigus group (vulgaris, vegetans, foliaceus, herpetiformis, brasiliensis). Clin Dermatol 29:432–436
89. Jonca N, Guerrin M, Hadjiolova K, Caubet C, Gallinaro H, Simon M, Serre G (2002) Corneodesmosin, a component of epidermal corneocyte desmosomes, displays homophilic adhesive properties. J Biol Chem 277:5024–5029
90. Katafiasz D, Smith LM, Wahl JK 3rd (2011) Slug (SNAI2) expression in oral SCC cells results in altered cell-cell adhesion and increased motility. Cell Adhes Migr 5:315–322
91. Kelly DE (1966) Fine structure of desmosomes, hemidesmosomes, and an adepidermal globular layer in developing newt epidermis. J Cell Biol 28:51–72
92. Khapare N, Kundu ST, Sehgal L, Sawant M, Priya R, Gosavi P, Gupta N, Alam H, Karkhanis M, Naik N, Vaidya MM, Dalal SN (2012) Plakophilin3 loss leads to an increase in PRL3 levels promoting K8 dephosphorylation, which is required for transformation and metastasis. PLoS One 7:e38561
93. Kitajima Y (2013) New insights into desmosome regulation and pemphigus blistering as a desmosome-remodeling disease. Kaohsiung J Med Sci 29:1–13
94. Kitajima Y (2014) 150th anniversary series: Desmosomes and autoimmune disease, perspective of dynamic desmosome remodeling and its impairments in pemphigus. Cell Commun Adhes 21:269–280
95. Klessner JL, Desai BV, Amargo EV, Getsios S, Green KJ (2009) EGFR and ADAMs cooperate to regulate shedding and endocytic trafficking of the desmosomal cadherin desmoglein 2. Mol Biol Cell 20:328–337
96. Kneisel A, Hertl M (2011a) Autoimmune bullous skin diseases. Part 1. Clinical manifestations. J Dtsch Dermatol Ges 9:844–856
97. Kneisel A, Hertl M (2011b) Autoimmune bullous skin diseases. Part 2. Diagnosis and therapy. J Dtsch Dermatol Ges 9:927–947
98. Ko CJ, McNiff JM (2014) Punctate pemphigus: an underreported direct immunofluorescence pattern. J Cutan Pathol 41:293–296
99. Koch PJ, Mahoney MG, Ishikawa H, Pulkkinen L, Uitto J, Shultz L, Murphy GF, Whitaker-Menezes D, Stanley JR (1997) Targeted disruption of the pemphigus vulgaris antigen (desmoglein 3) gene in mice causes loss of keratinocyte cell adhesion with a phenotype similar to pemphigus vulgaris. J Cell Biol 137:1091–1102
100. Koga H, Tsuruta D, Ohyama B, Ishii N, Hamada T, Ohata C, Furumura M, Hashimoto T (2013) Desmoglein 3, its pathogenecity and a possibility for therapeutic target in pemphigus vulgaris. Expert Opin Ther Targets 17:293–306
101. Kong CS, Cao H, Kwok S, Nguyen CM, Jordan RC, Beaudry VG, Attardi LD, Le QT (2013) Loss of the p53/p63 target PERP is an early event in oral carcinogenesis and correlates with higher rate of local relapse. Oral Surg Oral Med Oral Pathol Oral Radiol 115:95–103
102. Kowalczyk AP, Green KJ (2013) Structure, function, and regulation of desmosomes. Prog Mol Biol Transl Sci 116:95–118
103. Kurzen H, Munzing I, Hartschuh W (2003) Expression of desmosomal proteins in squamous cell carcinomas of the skin. J Cutan Pathol 30:621–630
104. Lambert J, Bracke S, Roy F van, Pas HH, Bonne S, De Schepper S (2010) Serum plakophilin-3 autoreactivity in paraneoplastic pemphigus. Br J Dermatol 163:630–632
105. Langenhan J, Dworschak J, Saschenbrecker S, Komorowski L, Schlumberger W, Stocker W, Westermann J, Recke A, Zillikens D, Schmidt E, Probst C (2014) Specific immunoadsorption of pathogenic autoantibodies in pemphigus requires the entire ectodomains of desmogleins. Exp Dermatol 23:253–259
106. Langer M, Duggan ES, Booth JL, Patel VI, Zander RA, Silasi-Mansat R, Ramani V, Veres TZ, Prenzler F, Sewald K, Williams DM, Coggeshall KM, Awasthi S, Lupu F, Burian D, Ballard JD, Braun A, Metcalf JP (2012) Bacillus anthracis lethal toxin reduces human alveolar epithelial barrier function. Infect Immun 80:4374–4387
107. Li X, Ishii N, Ohata C, Furumura M, Hashimoto T (2014) Signalling pathways in pemphigus vulgaris. Exp Dermatol 23:155–156
108. Mahmoud AM, Yang W, Bosland MC (2014) Soy isoflavones and prostate cancer: a review of molecular mechanisms. J Steroid Biochem Mol Biol 140:116–132
109. Mahoney MG, Aho S, Uitto J, Stanley JR (1998) The members of the plakin family of proteins recognized by paraneoplastic pemphigus antibodies include periplakin. J Invest Dermatol 111:308–313
110. Mahoney MG, Wang Z, Rothenberger K, Koch PJ, Amagai M, Stanley JR (1999a) Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris. J Clin Invest 103:461–468
111. Mahoney MG, Wang ZH, Stanley JR (1999b) Pemphigus vulgaris and pemphigus foliaceus antibodies are pathogenic in plasminogen activator knockout mice. J Invest Dermatol 113:22–25
112. Maia-Brigagao C, Morgado-Diaz JA, De Souza W (2012) Giardia disrupts the arrangement of tight, adherens and desmosomal junction proteins of intestinal cells. Parasitol Int 61:280–287
113. Mao X, Nagler AR, Farber SA, Choi EJ, Jackson LH, Leiferman KM, Ishii N, Hashimoto T, Amagai M, Zone JJ, Payne AS (2010) Autoimmunity to desmocollin 3 in pemphigus vulgaris. Am J Pathol 177:2724–2730
114. Mao X, Sano Y, Park JM, Payne AS (2011) p38 MAPK activation is downstream of the loss of intercellular adhesion in pemphigus vulgaris. J Biol Chem 286:1283–1291
115. Mao X, Li H, Sano Y, Gaestel M, Mo Park J, Payne AS (2014) MAPKAP kinase 2 (MK2)-dependent and -independent models of blister formation in pemphigus vulgaris. J Invest Dermatol 134:68–76
116. Marquina M, Espana A, Fernandez-Galar M, Lopez-Zabalza MJ (2008) The role of nitric oxide synthases in pemphigus vulgaris in a mouse model. Br J Dermatol 159:68–76
117. Mazzarello P, Calligaro AL, Calligaro A (2001) Giulio Bizzozero: a pioneer of cell biology. Nat Rev Mol Cell Biol 2:776–781
118. Milner Y, Sagi E, Timberg R, Michel B, Me‘te’zeau P, Goldberg M (1989) Binding modes of IgG from pemphigus autoimmune sera onto guinea pig keratinocytes and the fate of bound IgGs. J Cell Physiol 139:441–454
119. Mockenhaupt M, Idzko M, Grosber M, Schopf E, Norgauer J (2005) Epidemiology of staphylococcal scalded skin syndrome in Germany. J Invest Dermatol 124:700–703
120. Myklebust MP, Fluge O, Immervoll H, Skarstein A, Balteskard L, Bruland O, Dahl O (2012) Expression of DSG1 and DSC1 are prognostic markers in anal carcinoma patients. Br J Cancer 106:756–762
121. Nagai Y, Takeshita N, Saku T (1992) Histopathologic and ultrastructural studies of oral mucosa with Candida infection. J Oral Pathol Med 21:171–175
122. Nagaraju GP, Zafar SF, El-Rayes BF (2013) Pleiotropic effects of genistein in metabolic, inflammatory, and malignant diseases. Nutr Rev 71:562–572
123. Nava P, Laukoetter MG, Hopkins AM, Laur O, Gerner-Smidt K, Green KJ, Parkos CA, Nusrat A (2007) Desmoglein-2: a novel regulator of apoptosis in the intestinal epithelium. Mol Biol Cell 18:4565–4578
124. Nekrasova O, Green KJ (2013) Desmosome assembly and dynamics. Trends Cell Biol 23:537–546
125. Nguyen VT, Ndoye A, Grando SA (2000) Novel human alpha9 acetylcholine receptor regulating keratinocyte adhesion is targeted by pemphigus vulgaris autoimmunity. Am J Pathol 157:1377–1391
126. Nishifuji K, Olivry T, Ishii K, Iwasaki T, Amagai M (2007) IgG autoantibodies directed against desmoglein 3 cause dissociation of keratinocytes in canine pemphigus vulgaris and paraneoplastic pemphigus. Vet Immunol Immunopathol 117:209–221
127. O’Shea C, Fitzpatrick JE, Koch PJ (2014) Desmosomal defects in acantholytic squamous cell carcinomas. J Cutan Pathol 41:873–879
128. Odland GF (1958) The fine structure of the interrelationship of cells in the human epidermis. J Biophys Biochem Cytol 4:529–538
129. Ohyama B, Nishifuji K, Chan PT, Kawaguchi A, Yamashita T, Ishii N, Hamada T, Dainichi T, Koga H, Tsuruta D, Amagai M, Hashimoto T (2012) Epitope spreading is rarely found in pemphigus vulgaris by large-scale longitudinal study using desmoglein 2-based swapped molecules. J Invest Dermatol 132:1158–1168
130. Oktarina DA, Wier G van der, Diercks GF, Jonkman MF, Pas HH (2011) IgG-induced clustering of desmogleins 1 and 3 in skin of patients with pemphigus fits with the desmoglein nonassembly depletion hypothesis. Br J Dermatol 165:552–562
131. Oktarina DA, Poot AM, Kramer D, Diercks GF, Jonkman MF, Pas HH (2012) The IgG “lupus-band” deposition pattern of pemphigus erythematosus: association with the desmoglein 1 ectodomain as revealed by 3 cases. Arch Dermatol 148:1173–1178
132. Osada K, Seishima M, Kitajima Y (1997) Pemphigus IgG activates and translocates protein kinase C from the cytosol to the particulate/cytoskeleton fractions in human keratinocytes. J Invest Dermatol 108:482–487
133. Oshiro MM, Kim CJ, Wozniak RJ, Junk DJ, Munoz-Rodriguez JL, Burr JA, Fitzgerald M, Pawar SC, Cress AE, Domann FE, Futscher BW (2005) Epigenetic silencing of DSC3 is a common event in human breast cancer. Breast Cancer Res 7:R669–R680
134. Otsubo T, Hagiwara T, Tamura-Nakano M, Sezaki T, Miyake O, Hinohara C, Shimizu T, Yamada K, Dohi T, Kawamura YI (2015) Aberrant DNA hypermethylation reduces the expression of the desmosome-related molecule periplakin in esophageal squamous cell carcinoma. Cancer Med (in press)
135. Overton J (1962) Desmosome development in normal and reassociating cells in the early chick blastoderm. Dev Biol 4:532–548
136. Owen GR, Acehan D, Derr KD, Rice WJ, Stokes DL (2008) Cryoelectron tomography of isolated desmosomes. Biochem Soc Trans 36:173–179
137. Papagerakis S, Shabana AH, Pollock BH, Papagerakis P, Depondt J, Berdal A (2009) Altered desmoplakin expression at transcriptional and protein levels provides prognostic information in human oropharyngeal cancer. Hum Pathol 40:1320–1329
138. Patel GK (2004) Treatment of staphylococcal scalded skin syndrome. Expert Rev Anti Infect Ther 2:575–587
139. Patel HP, Diaz LA, Anhalt GJ, Labib RS, Takahashi Y (1984) Demonstration of pemphigus antibodies on the cell surface of murine epidermal cell monolayers and their internalization. J Invest Dermatol 83:409–415
140. Payne AS, Ishii K, Kacir S, Lin C, Li H, Hanakawa Y, Tsunoda K, Amagai M, Stanley JR, Siegel DL (2005) Genetic and functional characterization of human pemphigus vulgaris monoclonal autoantibodies isolated by phage display. J Clin Invest 115:888–899
141. Perez-Perez ME, Avalos-Diaz E, Herrera-Esparza R (2012) Autoantibodies in Senear-Usher syndrome: cross-reactivity or multiple autoimmunity? Autoimmune Dis 2012:296214
142. Phillips C, Kalantari-Dehaghi M, Marchenko S, Chernyavsky AI, Galitovskiy V, Gindi V, Chun S, Paslin D, Grando SA (2013) Is Grover’s disease an autoimmune dermatosis? Exp Dermatol 22:781–784
143. Pike LJ (2006) Rafts defined: a report on the Keystone Symposium on Lipid Rafts and Cell Function. J Lipid Res 47:1597–1598
144. Poot AM, Diercks GF, Kramer D, Schepens I, Klunder G, Hashimoto T, Borradori L, Jonkman MF, Pas HH (2013) Laboratory diagnosis of paraneoplastic pemphigus. Br J Dermatol 169:1016–1024
145. Probst C, Schlumberger W, Stocker W, Recke A, Schmidt E, Hashimoto T, Zhu XJ, Zillikens D, Komorowski L (2009) Development of ELISA for the specific determination of autoantibodies against envoplakin and periplakin in paraneoplastic pemphigus. Clin Chim Acta 410:13–18
146. Rafei D, Muller R, Ishii N, Llamazares M, Hashimoto T, Hertl M, Eming R (2011) IgG autoantibodies against desmocollin 3 in pemphigus sera induce loss of keratinocyte adhesion. Am J Pathol 178:718–723
147. Ramani VC, Hennings L, Haun RS (2008) Desmoglein 2 is a substrate of kallikrein 7 in pancreatic cancer. BMC Cancer 8:373
148. Resnik N, Sepcic K, Plemenitas A, Windoffer R, Leube R, Veranic P (2011) Desmosome assembly and cell-cell adhesion are membrane raft-dependent processes. J Biol Chem 286:1499–1507
149. Roberts BJ, Johnson KE, McGuinn KP, Saowapa J, Svoboda RA, Mahoney MG, Johnson KR, Wahl JK 3rd (2014) Palmitoylation of plakophilin is required for desmosome assembly. J Cell Sci 127:3782–3793
150. Rocha-Alvarez R, Ortega-Loayza AG, Friedman H, Campbell I, Aoki V, Rivitti EA, Dasher D, Li N, Diaz LA, Cooperative Group on Fogo Selvagem R (2007) Endemic pemphigus vulgaris. Arch Dermatol 143:895–899
151. Rock B, Martins CR, Theofilopoulos AN, Balderas RS, Anhalt GJ, Labib RS, Futamura S, Rivitti EA, Diaz LA (1989) The pathogenic effect of IgG4 autoantibodies in endemic pemphigus foliaceus (fogo selvagem). N Engl J Med 320:1463–1469
152. Rotzer V, Breit A, Waschke J, Spindler V (2014) Adducin is required for desmosomal cohesion in keratinocytes. J Biol Chem 289:14925–14940
153. Ruocco V, Ruocco E, Lo Schiavo A, Brunetti G, Guerrera LP, Wolf R (2013) Pemphigus: etiology, pathogenesis, and inducing or triggering factors: facts and controversies. Clin Dermatol 31:374–381
154. Saito H, Shimizu A, Tsunoda K, Amagai M, Ishiko A (2009) Subcellular localization of desmosomal components is different between desmoglein3 knockout mice and pemphigus vulgaris model mice. J Dermatol Sci 55:108–115
155. Saito M, Stahley SN, Caughman CY, Mao X, Tucker DK, Payne AS, Amagai M, Kowalczyk AP (2012) Signaling dependent and independent mechanisms in pemphigus vulgaris blister formation. PLoS One 7:e50696
156. Saleh MA, Ishii K, Yamagami J, Shirakata Y, Hashimoto K, Amagai M (2012) Pathogenic anti-desmoglein 3 mAbs cloned from a paraneoplastic pemphigus patient by phage display. J Invest Dermatol 132:1141–1148
157. Sams WM Jr, Jordon RE (1971) Correlation of pemphigoid and pemphigus antibody titres with activity of disease. Br J Dermatol 84:7–13
158. Sanchez-Carpintero I, Espana A, Pelacho B, Lopez Moratalla N, Rubenstein DS, Diaz LA, Lopez-Zabalza MJ (2004) In vivo blockade of pemphigus vulgaris acantholysis by inhibition of intracellular signal transduction cascades. Br J Dermatol 151:565–570
159. Sato M, Aoyama Y, Kitajima Y (2000) Assembly pathway of desmoglein 3 to desmosomes and its perturbation by pemphigus vulgaris-IgG in cultured keratinocytes, as revealed by time-lapsed labeling immunoelectron microscopy. Lab Invest 80:1583–1592
160. Savagner P, Yamada KM, Thiery JP (1997) The zinc-finger protein slug causes desmosome dissociation, an initial and necessary step for growth factor-induced epithelial-mesenchymal transition. J Cell Biol 137:1403–1419
161. Sayar BS, Ruegg S, Schmidt E, Sibilia M, Siffert M, Suter MM, Galichet A, Muller EJ (2014) EGFR inhibitors erlotinib and lapatinib ameliorate epidermal blistering in pemphigus vulgaris in a non-linear, V-shaped relationship. Exp Dermatol 23:33–38
162. Schiltz JR, Michel B (1976) Production of epidermal acantholysis in normal human skin in vitro by the IgG fraction from pemphigus serum. J Invest Dermatol 67:254–260
163. Schmitt CJ, Franke WW, Goerdt S, Falkowska-Hansen B, Rickelt S, Peitsch WK (2007) Homo- and heterotypic cell contacts in malignant melanoma cells and desmoglein 2 as a novel solitary surface glycoprotein. J Invest Dermatol 127:2191–2206
164. Schulze K, Galichet A, Sayar BS, Scothern A, Howald D, Zymann H, Siffert M, Zenhausern D, Bolli R, Koch PJ, Garrod D, Suter MM, Muller EJ (2012) An adult passive transfer mouse model to study desmoglein 3 signaling in pemphigus vulgaris. J Invest Dermatol 132:346–355
165. Seishima M, Iwasaki-Bessho Y, Itoh Y, Nozawa Y, Amagai M, Kitajima Y (1999) Phosphatidylcholine-specific phospholipase C, but not phospholipase D, is involved in pemphigus IgG-induced signal transduction. Arch Dermatol Res 291:606–613
166. Seishima M, Oda M, Oyama Z, Yoshimura T, Yamazaki F, Aoki T, Nei M, Hashimoto T (2004) Antibody titers to desmogleins 1 and 3 in a patient with paraneoplastic pemphigus associated with follicular dendritic cell sarcoma. Arch Dermatol 140:1500–1503
167. Sekiguchi M, Futei Y, Fujii Y, Iwasaki T, Nishikawa T, Amagai M (2001) Dominant autoimmune epitopes recognized by pemphigus antibodies map to the N-terminal adhesive region of desmogleins. J Immunol 167:5439–5448
168. Sevilla LM, Nachat R, Groot KR, Watt FM (2008) Kazrin regulates keratinocyte cytoskeletal networks, intercellular junctions and differentiation. J Cell Sci 121:3561–3569
169. Sharma P, Mao X, Payne AS (2007) Beyond steric hindrance: the role of adhesion signaling pathways in the pathogenesis of pemphigus. J Dermatol Sci 48:1–14
170. Shi J, Sugrue SP (2000) Dissection of protein linkage between keratins and pinin, a protein with dual location at desmosome-intermediate filament complex and in the nucleus. J Biol Chem 275:14910–14915
171. Shimizu A, Ishiko A, Ota T, Tsunoda K, Amagai M, Nishikawa T (2004) IgG binds to desmoglein 3 in desmosomes and causes a desmosomal split without keratin retraction in a pemphigus mouse model. J Invest Dermatol 122:1145–1153
172. Simons K, Ehehalt R (2002) Cholesterol, lipid rafts, and disease. J Clin Invest 110:597–603
173. Simons K, Sampaio JL (2011) Membrane organization and lipid rafts. Cold Spring Harbor Perspect Biol 3:a004697
174. Simons K, Toomre D (2000) Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 1:31–39
175. Simpson CL, Patel DM, Green KJ (2011) Deconstructing the skin: cytoarchitectural determinants of epidermal morphogenesis. Nat Rev Mol Cell Biol 12:565–580
176. Sobolik-Delmaire T, Katafiasz D, Keim SA, Mahoney MG, Wahl JK 3rd (2007) Decreased plakophilin-1 expression promotes increased motility in head and neck squamous cell carcinoma cells. Cell Commun Adhes 14:99–109
177. Sonnenberg A, Liem RK (2007) Plakins in development and disease. Exp Cell Res 313:2189–2203
178. Spindler V, Waschke J (2011) Role of Rho GTPases in desmosomal adhesion and pemphigus pathogenesis. Ann Anat 193:177–180
179. Stahley SN, Saito M, Faundez V, Koval M, Mattheyses AL, Kowalczyk AP (2014) Desmosome assembly and disassembly are membrane raft-dependent. PLoS One 9:e87809
180. Stanley JR, Amagai M (2006) Pemphigus, bullous impetigo, and the staphylococcal scalded-skin syndrome. N Engl J Med 355:1800–1810
181. Steffen C, Thomas D (2003) The men behind the eponym: Francis E. Senear, Barney Usher, and the Senear-Usher syndrome. Am J Dermatopathol 25:432–436
182. Stokes DL (2007) Desmosomes from a structural perspective. Curr Opin Cell Biol 19:565–571
183. Thiery JP, Chopin D (1999) Epithelial cell plasticity in development and tumor progression. Cancer Metastasis Rev 18:31–42
184. Thomason HA, Scothern A, McHarg S, Garrod DR (2010) Desmosomes: adhesive strength and signalling in health and disease. Biochem J 429:419–433
185. Trojan L, Schaaf A, Steidler A, Haak M, Thalmann G, Knoll T, Gretz N, Alken P, Michel MS (2005) Identification of metastasis-associated genes in prostate cancer by genetic profiling of human prostate cancer cell lines. Anticancer Res 25:183–191
186. Tsunoda K, Ota T, Aoki M, Yamada T, Nagai T, Nakagawa T, Koyasu S, Nishikawa T, Amagai M (2003) Induction of pemphigus phenotype by a mouse monoclonal antibody against the amino-terminal adhesive interface of desmoglein 3. J Immunol 170:2170–2178
187. Tsunoda K, Ota T, Saito M, Hata T, Shimizu A, Ishiko A, Yamada T, Nakagawa T, Kowalczyk AP, Amagai M (2011) Pathogenic relevance of IgG and IgM antibodies against desmoglein 3 in blister formation in pemphigus vulgaris. Am J Pathol 179:795–806
188. Tsuruta D, Ishii N, Hamada T, Ohyama B, Fukuda S, Koga H, Imamura K, Kobayashi H, Karashima T, Nakama T, Dainichi T, Hashimoto T (2011) IgA pemphigus. Clin Dermatol 29:437–442
189. Tucker DK, Stahley SN, Kowalczyk AP (2014) Plakophilin-1 protects keratinocytes from pemphigus vulgaris IgG by forming calcium-independent desmosomes. J Invest Dermatol 134:1033–1043
190. Vasioukhin V, Bauer C, Yin M, Fuchs E (2000) Directed actin polymerization is the driving force for epithelial cell-cell adhesion. Cell 100:209–219
191. Wallis S, Lloyd S, Wise I, Ireland G, Fleming TP, Garrod D (2000) The alpha isoform of protein kinase C is involved in signaling the response of desmosomes to wounding in cultured epithelial cells. Mol Biol Cell 11:1077–1092
192. Wang H, Li ZY, Liu Y, Persson J, Beyer I, Moller T, Koyuncu D, Drescher MR, Strauss R, Zhang XB, Wahl JK 3rd, Urban N, Drescher C, Hemminki A, Fender P, Lieber A (2011) Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14. Nat Med 17:96–104
193. Waschke J, Spindler V, Bruggeman P, Zillikens D, Schmidt G, Drenckhahn D (2006) Inhibition of Rho A activity causes pemphigus skin blistering. J Cell Biol 175:721–727
194. Wier G van der, Pas HH, Kramer D, Diercks GF, Jonkman MF (2014) Smaller desmosomes are seen in the skin of pemphigus patients with anti-desmoglein 1 antibodies but not in patients with anti-desmoglein 3 antibodies. J Invest Dermatol 134:2287–2290
195. Williamson L, Raess NA, Caldelari R, Zakher A, de Bruin A, Posthaus H, Bolli R, Hunziker T, Suter MM, Muller EJ (2006) Pemphigus vulgaris identifies plakoglobin as key suppressor of c-Myc in the skin. EMBO J 25:3298–3309
196. Wong MP, Cheang M, Yorida E, Coldman A, Gilks CB, Huntsman D, Berean K (2008) Loss of desmoglein 1 expression associated with worse prognosis in head and neck squamous cell carcinoma patients. Pathology 40:611–616
197. Yamamoto Y, Aoyama Y, Shu E, Tsunoda K, Amagai M, Kitajima Y (2007) Anti-desmoglein 3 (Dsg3) monoclonal antibodies deplete desmosomes of Dsg3 and differ in their Dsg3-depleting activities related to pathogenicity. J Biol Chem 282:17866–17876
198. Yang L, Chen Y, Cui T, Knosel T, Zhang Q, Albring KF, Huber O, Petersen I (2012) Desmoplakin acts as a tumor suppressor by inhibition of the Wnt/beta-catenin signaling pathway in human lung cancer. Carcinogenesis 33:1863–1870
199. Yashiro M, Nishioka N, Hirakawa K (2006) Decreased expression of the adhesion molecule desmoglein-2 is associated with diffuse-type gastric carcinoma. Eur J Cancer 42:2397–2403
200. Ye X, Zhang HM, Qiu Y, Hanson PJ, Hemida MG, Wei W, Hoodless PA, Chu F, Yang D (2014) Coxsackievirus-induced miR-21 disrupts cardiomyocyte interactions via the downregulation of intercalated disk components. PLoS Pathog 10:e1004070
201. Yong AA, Tey HL (2013) Paraneoplastic pemphigus. Australas J Dermatol 54:241–250